Publications

5677 Results

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu over-expressing metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Authors
J Mezzanotte-Sharpe;A O'Neill;I Mayer;C Arteaga;X Yang;L Wagner;D Celia;N Meropol;R Alpaugh;T Saphner;R Swaney;K Hoelzer;W Gradishar;V Abramson;K Sundaram;S Jilani;E Perez;N Lin;M Jahanzeb;G Sledge;S Reid
Journal / Conference
Breast Cancer Research and Treatment Sep;207(2):275-282
Year
2024
Research Committee(s)
Breast
PMID
PMID38967884
PMC
PMC11297090
Study Number(s)
CTSU/E1105

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A

Authors
S Gettinger;Z Song;K Reckamp;J Moscow;R Gray;V Wang;L McShane;L Rubinstein;D Patton;P Willams;S Hamilton;X Kong;J Tricoli;B Conley;C Arteaga;L Harris;P O'Dwyer;A Chen;K Flaherty
Journal / Conference
JCO Precision Oncology Jul:8:e2300725
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID38986051
Study Number(s)
CTSU/EAY131

Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer

Authors
J Alvarez;Q Shi;A Dasari;J Garcia-Aguilar;H Sanoff;T George;T Hong;G Yothers;P Philip;G Nelson;T Al Baghdadi;O Alese;W Zambare;D Omer;F Verheig;A Bercz;M Kim;J Buckley;H Williams;M George;R Garcia;P Gallagher;E O'Reilly;J Meyerhardt;J Crawley;A Shergill;N Horvat;P Romesser;W Hall;J Smith
Journal / Conference
BMC Cancer Jul 26;24(1):901
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID39060961
PMC
PMC11282593

DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations

Authors
F Innocenti;W Mu;X Qu;F Ou;O Kabbarah;C Blanke;A Venook;H Lenz;N Rashid
Journal / Conference
Journal of Clinical Oncology Feb 1;42(4):399-409
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID37992266
PMC
PMC10824387
Study Number(s)
CTSU/C80405

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial

Authors
G Gebrael;Y Jo;U Swami;M Plets;C Chehade;A Narang;S Gupta;Z Myint;N Sayegh;C Tangen;M Hussain;T Dorff;P Lara;S Lerner;I Thompson;N Agarwal
Journal / Conference
JAMA Network Open Jul 1;7(7):e2419966
Year
2024
Research Committee(s)
Genitourinary
PMID
PMID38980676
PMC
PMC11234233
Study Number(s)
S1216

Letter: Survival After Selenium and Vitamin E Supplementation: Long-Term Followup of the Selenium and Vitamin E Cancer Prevention Trial

Authors
C Till;P Goodman;C Tangen;MS Lucia;I Thompson
Journal / Conference
Journal of Urology Jul;212(1):228-229
Year
2024
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID38657020
PMC
PMC11218905
Study Number(s)
S0000

Genome-Wide Gene-Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk

Authors
M Stern;J Sanchez Mendez;A Kim;M Obon-Santacana;F Moratalla-Navarro;V Martin;V Moreno;Y Lin;S Bien;C Qu;Y Su;E White;T Harrison;J Huyghe;C Tangen;P Newcomb;A Phipps;C Thomas;E Kawaguchi;J Lewinger;J Morrison;D Conti;J Wang;D Thomas;E Platz;K Visvanathan;T Keku;C Newton;C Um;A Kundaje;A Shcherbina;N Murphy;M Gunter;N Dimou;N Papadimitriou;S Bezieau;F van Duijnhoven;S Mannisto;G Rennert;A Wolk;M Hoffmeister;H Brenner;J Chang-Claude;Y Tian;L LeMarchand;M Cotterchio;K Tsilidis;D Bishop;Y Melaku;B Lynch;D Buchanan;C Ulrich;J Ose;A Peoples;A Pellatt;M Devall;P Campbell;D Albanes;S Weinstein;S Berndt;S Gruber;E Ruiz-Narvaez;M Song;A Joshi;D Drew;J Petrick;A Chan;M Giannakis;U Peters;L Hsu;W Gauderman
Journal / Conference
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Mar 1;33(3):400-410
Year
2024
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID38112776
PMC
PMC11343583
Study Number(s)
SWOG-9217

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Authors
V Stearns;O Jegede;V Chang;T Skaar;J Berenberg;R Nand;A Shafqat;N Jacobs;W Luginbuhl;P Gilman;A Benson;J Goodman;G Buchschacher;NL Henry;C Loprinzi;P Flynn;E Mitchell;M Fisch;J Sparano;L Wagner
Journal / Conference
Clinical Cancer Research Jul 1;30(13):2709-2718
Year
2024
Research Committee(s)
Breast
PMID
PMID38640040
PMC
PMC11287923
Study Number(s)
CTSU/E1Z11

Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04

Authors
J Peipert;J Roydhouse;M Tighiouart;NL Henry;S Kim;R Hays;A Rogatko;G Yothers;P Ganz
Journal / Conference
Quality of Life Research Jul 30. doi: 10.1007/s11136-024-03746-5. Online ahead of print
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID39080091

Interventions addressing health-related social needs among patients with cancer

Authors
E Graboyes;S Lee;S Lindau;A Adams;B Adjei;M Brown;G Sadigh;A Incudine;R Carlos;S Ramsey;R Bangs
Journal / Conference
JNCI-Journal of the National Cancer Institute Apr 5;116(4):497-505
Year
2024
Research Committee(s)
Cancer Care Delivery
PMID
PMID38175791